Dynamic changes in endothelial cell adhesion molecule nepmucin/CD300LG expression under physiological and pathological conditions

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Umemoto, Eiji ^a,b   Takeda, Akira ^a   Jin, Soojung ^a,e   Luo, Zhijuan ^a,f   Nakahogi, Naoki ^a   Hayasaka, Haruko ^a,b   Lee, Chun Man ^c   Tanaka, Toshiyuki ^d   Miyasaka, Masayuki ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY HOSPITAL   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

^e Dong Eui University   (South Korea)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD300LG PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR;

ANIMAL; ANTIBODY SPECIFICITY; CYTOLOGY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; LYMPH NODE; LYMPHOCYTE; METABOLISM; MICROVASCULATURE; MOUSE; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; DOWN-REGULATION; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LYMPH NODES; LYMPHOCYTES; MICE; MICROVESSELS; ORGAN SPECIFICITY; PANCREATIC NEOPLASMS; RECEPTORS, IMMUNOLOGIC;

EID: 84893442895     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083681     Document Type: Article

References (43)

1. Aird WC (2012) Endothelial cell heterogeneity. Cold Spring Harb Perspect Med 2: a006429.
2. Langenkamp E, Molema G (2009) Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer. Cell Tissue Res 335: 205-222.
3. Atkins GB, Jain MK, Hamik A (2011) Endothelial differentiation: molecular mechanisms of specification and heterogeneity. Arterioscler Thromb Vasc Biol 31: 1476-1484.
4. Garlanda C, Dejana E (1997) Heterogeneity of endothelial cells. Specific markers. Arterioscler Thromb Vasc Biol 17: 1193-1202. (Pubitemid 27329839)
5. Chi JT, Chang HY, Haraldsen G, Jahnsen FL, Troyanskaya OG, et al. (2003) Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci USA 100: 10623-10628. (Pubitemid 37140079)
6. Muller WA, Ratti CM, McDonnell SL, Cohn ZA (1989) A human endothelial cell-restricted, externally disposed plasmalemmal protein enriched in intercellular junctions. J Exp Med 170: 399-414. (Pubitemid 19204271)
7. Ioannidou S, Deinhardt K, Miotla J, Bradley J, Cheung E, et al. (2006) An in vitro assay reveals a role for the diaphragm protein PV-1 in endothelial fenestra morphogenesis. Proc Natl Acad Sci USA 103: 16770-16775. (Pubitemid 44737328)
8. Niemela H, Elima K, Henttinen T, Irjala H, Salmi M, et al. (2005) Molecular identification of PAL-E, a widely used endothelial-cell marker. Blood 106: 3405-3409. (Pubitemid 41609174)
9. Stan RV, Ghitescu L, Jacobson BS, Palade GE (1999) Isolation, cloning, and localization of rat PV-1, a novel endothelial caveolar protein. J Cell Biol 145: 1189-1198. (Pubitemid 29293631)
10. Miyasaka M, Tanaka T (2004) Lymphocyte trafficking across high endothelial venules: dogmas and enigmas. Nat Rev Immunol 4: 360-370. (Pubitemid 38649278)
11. Girard J-P, Moussion C, Forster R (2012) HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol 12: 762-773.
12. Uchimura K, Rosen SD (2006) Sulfated L-selectin ligands as a therapeutic target in chronic inflammation. Trends Immunol 27: 559-565. (Pubitemid 44708834)
13. Umemoto E, Hayasaka H, Bai Z, Cai L, Yonekura S, et al. (2011) Novel regulators of lymphocyte trafficking across high endothelial venules. Crit Rev Immunol 31: 147-169.
14. Rosen SD (2004) Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol 22: 129-156.
15. Baluk P, Hashizume H, McDonald DM (2005) Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15: 102-111. (Pubitemid 40127638)
16. Melder RJ, Koenig GC, Witwer BP, Safabakhsh N, Munn LL, et al. (1996) During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nat Med 2: 992-997. (Pubitemid 26306837)
17. Kraling BM, Razon MJ, Boon LM, Zurakowski D, Seachord C, et al. (1996) Eselectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol 148: 1181-1191. (Pubitemid 26108255)
18. Kobayashi M, Mitoma J, Nakamura N, Katsuyama T, Nakayama J, et al. (2004) Induction of peripheral lymph node addressin in human gastric mucosa infected by Helicobacter pylori. Proc Natl Acad Sci USA 101: 17807-17812. (Pubitemid 40051968)
19. Hanninen A, Taylor C, Streeter PR, Stark LS, Sarte JM, et al. (1993) Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Invest 92: 2509-2515. (Pubitemid 23333561)
20. Faveeuw C, Gagnerault MC, Lepault F (1994) Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabetic mice. J Immunol 152: 5969-5978. (Pubitemid 24174179)
21. Umemoto E, Tanaka T, Kanda H, Jin S, Tohya K, et al. (2006) Nepmucin, a novel HEV sialomucin, mediates L-selectin-dependent lymphocyte rolling and promotes lymphocyte adhesion under flow. J Exp Med 203: 1603-1614. (Pubitemid 43877619)
22. Chung DH, Humphrey MB, Nakamura MC, Ginzinger DG, Seaman WE, et al. (2003) CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. J Immunol 171: 6541-6548. (Pubitemid 37532084)
23. Jin S, Umemoto E, Tanaka T, Shimomura Y, Tohya K, et al. (2008) Nepmucin/CLM-9, an Ig domain-containing sialomucin in vascular endothelial cells, promotes lymphocyte transendothelial migration in vitro. FEBS Lett 582: 3018-3024.
24. Albrechtsen A, Grarup N, Li Y, Sparso T, Tian G, et al. (2013) Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia 56: 298-310.
25. Izawa D, Tanaka T, Saito K, Ogihara H, Usui T, et al. (1999) Expression profile of active genes in mouse lymph node high endothelial cells. Int Immunol 11:1989-1998.
26. Tanaka T, Tsudo M, Karasuyama H, Kitamura F, Kono T, et al. (1991) A novel monoclonal antibody against murine IL-2 receptor b-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J Immunol 147: 2222-2228.
27. Lee CM, Tanaka T, Murai T, Kondo M, Kimura J, et al. (2002) Novel chondroitin sulfate-binding cationic liposomes loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivo. Cancer Res 62: 4282-4288. (Pubitemid 34827283)
28. Kunkel EJ, Ramos CL, Steeber DA, Müller W, Wagner N,et al. (1998) The roles of L-selectin, b7 integrins, and P-selectin in leukocyte rolling and adhesion in high endothelial venules of Peyer's patches. J Immunol 161: 2449-56. (Pubitemid 28397061)
29. Murfee WL, Skalak TC, Peirce SM (2005) Differential arterial/venous expression of NG2 proteoglycan in perivascular cells along microvessels: identifying a venule-specific phenotype. Microcirculation 12: 151-160. (Pubitemid 40485628)
30. Katakai T (2012) Marginal reticular cells: a stromal subset directly descended from the lymphoid tissue organizer. Front Immunol 3: 200.
31. Kashiwazaki M, Tanaka T, Kanda H, Ebisuno Y, Izawa D, et al. (2003) A high endothelial venule-expressing promiscuous chemokine receptor DARC can bind inflammatory, but not lymphoid, chemokines and is dispensable for lymphocyte homing under physiological conditions. Int Immunol 15:1219-1227. (Pubitemid 37220495)
32. Lacorre DA, Baekkevold ES, Garrido I, Brandtzaeg P, Haraldsen G, et al. (2004) Plasticity of endothelial cells: rapid dedifferentiation of freshly isolated high endothelial venule endothelial cells outside the lymphoid tissue microenvironment. Blood 103:4164-4172. (Pubitemid 38685358)
33. Thurston G, Baluk P, McDonald DM (2000) Determinants of endothelial cell phenotype in venules. Microcirculation 7: 67-80.
34. Ochoa CD, Wu S, Stevens T (2010) New developments in lung endothelial heterogeneity: Von Willebrand factor, P-selectin, and the Weibel-Palade body. Semin Thromb Hemost 36: 301-308.
35. Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF Jr, et al. (1993) Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress- responsive element. Proc Natl Acad Sci USA 90: 7908.
36. Almendro N, Bellon T, Rius C, Lastres P, Langa C, et al. (1996) Cloning of the human platelet endothelial cell adhesion molecule-1 promoter and its tissue-specific expression. Structural and functional characterization. J Immunol 157: 5411-5421. (Pubitemid 126448960)
37. Davis ME, Grumbach IM, Fukai T, Cutchins A, Harrison DG (2004) Shear stress regulates endothelial nitric-oxide synthase promoter activity through nuclear factor kB binding. J Biol Chem 279: 163-168. (Pubitemid 38044811)
38. Shyy JY, Lin MC, Han J, Lu Y, Petrime M, et al. (1995) The cis-acting phorbol ester "12-O-tetradecanoylphorbol 13-acetate"-responsive element is involved in shear stress-induced monocyte chemotactic protein 1 gene expression. Proc Natl Acad Sci USA 92: 8069-8073.
39. Oh P, Li Y, Yu J, Durr E, Krasinska KM, et al. (2004) Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 429: 629-635. (Pubitemid 38812308)
40. Arap W, Kolonin MG, Trepel M, Lahdenranta J, Cardo-Vila M, et al. (2002) Steps toward mapping the human vasculature by phage display. Nat Med 8: 121-127. (Pubitemid 34155122)
41. Minami T, Aird WC (2005) Endothelial cell gene regulation. Trends Cardiovasc Med 15: 174-184.
42. Liu J, Yuan L, Molema G, Regan E, Janes L, et al. (2011) Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle. Blood 117: 342-351.
43. Minami T, Donovan DJ, Tsai JC, Rosenberg RD, Aird WC (2002) Differential regulation of the von Willebrand factor and Flt-1 promoters in the endothelium of hypoxanthine phosphoribosyltransferase-targeted mice. Blood 100: 4019-4025. (Pubitemid 35396868)